Identification and examination of low-risk patients. Arch Intern Med. 1985;145:65 9. 111. Pozen MW, D Agostino RB, Selker HP, et al. A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart dis- ease.Aprospectivemulticenterclinicaltrial.NEnglJMed.1984;310:1273 8. 112. Selker HP, Griffith JL, D Agostino RB. A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospec- tive use. A time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study. Med Care. 1991;29:610 27. 113. Henrikson CA, Howell EE, Bush DE, et al. Chest pain relief by nitro- glycerin does not predict active coronary artery disease. Ann Intern Med. 2003;139: 979 86. 114. Swap CJ, Nagurney JT. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. JAMA. 2005;294:2623 9. 115. Brieger DB, Mak KH, White HD, et al. Benefit of early sustained reper- fusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries. Am J Cardiol. 1998;81:282 7. 116. Mega JL, Hochman JS, Scirica BM, et al. Clinical features and outcomes of women with unstable ischemic heart disease: observations from meta- bolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36). Circulation. 2010;121:1809 17. 117. Holmes DR Jr., White HD, Pieper KS, et al. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol. 1999;33:412 9. 118. White HD, Barbash GI, Califf RM, et al. Age and outcome with con- temporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation. 1996;94:1826 33. 119. Michos ED, Vasamreddy CR, Becker DM, et al. 